Nancy J. Hutson - 16 Aug 2021 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
16 Aug 2021
Net transactions value
+$17,040
Form type
4
Filing time
17 Aug 2021, 16:39:43 UTC
Previous filing
15 Jun 2021
Next filing
20 May 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Purchase $17,040 +3,000 +30% $5.68 13,000 16 Aug 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.